Fiji vs Lithuania: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Lithuania
100.0%
in 2024
Fiji rank
1st
Lithuania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Lithuania
How they compare
Fiji currently reports 100.0% against 100.0% in Lithuania, a difference of 0.0%.
The two have swapped places 1 time across 18 shared years of data; in 2006 it was Fiji ahead.
Fiji ranks 1st and Lithuania ranks 1st of 180 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.7% | 98.7% | 32.0% | Lithuania |
| 2010s | 48.1% | 100.0% | 51.9% | Lithuania |
| 2020s | 81.8% | 100.0% | 18.2% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Lithuania?
- Fiji, at 100.0% against 100.0% in Lithuania as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Lithuania?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Lithuania?
- 18 years are reported by both, from 2006 to 2024.
- How do Fiji and Lithuania rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Lithuania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.